Literature DB >> 7731710

Fibroblast growth factor receptors display both common and distinct signaling pathways.

E Shaoul1, R Reich-Slotky, B Berman, D Ron.   

Abstract

We compared the mitogenic and signaling pathways of three Fibroblast Growth Factor Receptors (FGFRs), FGFR1, KGFR and FGFR4 in the same cell line. Each receptor was expressed in L6E9 rat myoblasts that do not normally express detectable levels of FGFRs and clones that express comparable levels of each receptor were selected. Our results show that FGFs induce an effective survival and growth of FGFR1 and KGFR expressing cells. In addition, these cells exhibit a morphology that is reminiscent of that of malignantly transformed cells and display anchorage independent growth in a ligand dependent manner. Unlike KGFR and FGFR1, FGFR4 mediates a less effective growth, and cells overexpressing this receptor do not undergo any morphological changes nor do they display an anchorage independent growth in response to FGFs. All three receptors exhibit both quantitative and qualitative differences in their ability to induce tyrosine phosphorylation of cellular substrates. Both FGFR1 and KGFR induce strong phosphorylation of phospholipase C-gamma and a 90 kDa protein, while FGFR4 induces a relatively weak phosphorylation of phospholipase C-gamma and completely fails to induce phosphorylation of the 90 kDa. The three receptors also induce phosphorylation of the mitogen activated protein kinases (MAPK) but the effect of FGFR1 is far stronger than that of the other two receptors. Since FGFR4 is expressed in myoblasts in vivo, we examined whether this receptor can function in the differentiation pathway of myoblasts. Contrary to its weak mitogenic activity, FGFR4 effectively mediates the inhibition of myogenic differentiation in L6E9 cells and also suppresses the expression of the myogenic regulatory protein myogenin. Taken together, our results suggest that the signaling mechanism of FGFR4 differs from that of FGFR1 and KGFR, and that the primary role of FGFR4 in myoblasts may be the maintenance of their non differentiated state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731710

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway.

Authors:  Po Zhao; Giuseppina Caretti; Stephanie Mitchell; Wallace L McKeehan; Adele L Boskey; Lauren M Pachman; Vittorio Sartorelli; Eric P Hoffman
Journal:  J Biol Chem       Date:  2005-11-02       Impact factor: 5.157

2.  FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation.

Authors:  Boguslaw A Kwiatkowski; Irina Kirillova; Robert E Richard; David Israeli; Zipora Yablonka-Reuveni
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

3.  Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.

Authors:  Alexander Grabner; Ansel P Amaral; Karla Schramm; Saurav Singh; Alexis Sloan; Christopher Yanucil; Jihe Li; Lina A Shehadeh; Joshua M Hare; Valentin David; Aline Martin; Alessia Fornoni; Giovana Seno Di Marco; Dominik Kentrup; Stefan Reuter; Anna B Mayer; Hermann Pavenstädt; Jörg Stypmann; Christian Kuhn; Susanne Hille; Norbert Frey; Maren Leifheit-Nestler; Beatrice Richter; Dieter Haffner; Reimar Abraham; Johannes Bange; Bianca Sperl; Axel Ullrich; Marcus Brand; Myles Wolf; Christian Faul
Journal:  Cell Metab       Date:  2015-10-01       Impact factor: 27.287

4.  Linc-RAM is required for FGF2 function in regulating myogenic cell differentiation.

Authors:  Yixia Zhao; Fengqi Cao; Xiaohua Yu; Chuyan Chen; Jiao Meng; Ran Zhong; Yong Zhang; Dahai Zhu
Journal:  RNA Biol       Date:  2018-02-09       Impact factor: 4.652

5.  Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways.

Authors:  D J Milasincic; M R Calera; S R Farmer; P F Pilch
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization.

Authors:  A Wiedłocha; P O Falnes; A Rapak; R Muñoz; O Klingenberg; S Olsnes
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

7.  The fibroblast growth factor receptor-1 is necessary for the induction of neurite outgrowth in PC12 cells by aFGF.

Authors:  H Y Lin; J Xu; D M Ornitz; S Halegoua; M J Hayman
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

8.  Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.

Authors:  Yongde Luo; Chaofeng Yang; Weiqin Lu; Rui Xie; Chengliu Jin; Peng Huang; Fen Wang; Wallace L McKeehan
Journal:  J Biol Chem       Date:  2010-07-23       Impact factor: 5.157

9.  Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation.

Authors:  Luke Y S Oh; Adam Denninger; Jennifer S Colvin; Aditee Vyas; Shubha Tole; David M Ornitz; Rashmi Bansal
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

Review 10.  Molecular pathology of the fibroblast growth factor family.

Authors:  Pavel Krejci; Jirina Prochazkova; Vitezslav Bryja; Alois Kozubik; William R Wilcox
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.